Migraine Disorders  >>  telcagepant (MK-0974)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
telcagepant (MK-0974) / Merck (MSD)
NCT01421277: Study of Treatment Used for Migraine Headaches (MK-0974-076)

Terminated
N/A
216
NA
Statin Therapy
Merck Sharp & Dohme LLC
Migraine
03/12
03/12

Download Options